Leadership

Curogen’s Leadership is consisted with professional executive members with biotechnology and pharmaceutical backgrounds, collective experience, and broad visions for the future. Each one of our members leads us to broadening and developing our pipeline, and paves Curogen’s way into contributing to humanity’s health.

Executive Team

  • Chang-Woo Lee

    Chang-Woo Lee

    Chief Executive Officer (CEO)

    Sungkyunkwan University, College of Medicine, Professor

    Harvard Medical School, Post-Doctor

  • Jehoon Yang

    Jehoon Yang

    Chief Medical Officer (CMO)

    National Institute of Health, Post-Doctoral Fellow

    Gyeongsang National University, DVM/PhD  

  • Hyun-Soo Kim

    Hyun-Soo Kim

    Chief Scientific Officer (CSO)

    Samsung Biomedical Research Institute, Senior Researcher

    Sungkyunkwan University, College of Medicine, PhD

  • Bo-Kyoung Kim

    Bo-Kyoung Kim

    Chief Technical Officer (CTO)

    HANDOK Inc., Medicinal Chemistry Senior Researcher

    Gwangju Institute of Science and Technology (GIST), PhD  

  • Hye Jin Yang

    Hye Jin Yang

    Chief Strategy Officer (CSO)

    JW CreaGene, Senior Researcher

    Kyung Hee University, PhD  

  • Angela Jihyun Lee

    Angela Jihyun Lee

    Global Business Development Head

    Pierre Fabre Group

    Chung-Ang University

Board of Directors

  • Craig D. Gordon, MD

    gordon.png

    Gordon MD Global Investments, Founder & CEO

    The Capital Group, Equity Investment Analyst

    Cowen Group, Biotechnology Equity Investment Analyst

    University of Miami, Miller School of Medicine, MD

  • Jaeyeol An, PhD

    an.png

    Partners Investment, Managing Director

    Seoul National University,College of Medicine MS/PhD

    Genexine, Project Manager

    Samsung Medical Center, Researcer

     

  • Kiho Choi, MBA

    kihochoi.jpg

    Sungkyunkwan University, Global Entrepreneur Graduate School, Professor

    Yonsei University, MBA

    Stanford Research Institute International, Country Manager

    Strategic Investment Group of Intel Capital, MD

  • Sungjune Hong, LLM

    4.jpg

    Genexine Inc., CEO

    Vanderbilt Law School, LLM

    KICPA/AICPA/New York Bar Member

    Handok, CFO

    Rokit Healthcare, President & COO

     

  • Hyunsoo Kim, JD

    5.jpg

    Attorney at Law/Audit

    Sungkyunkwan Univeresity, Law School

    Hanhwa, Attorney at Law

Scientific Advisory Board

Clinical Studies

  • Sung-Hwan Park, MD/PhD

    박성환.png

    The Catholic University of Korea Seoul St. Mary's Hospital, Division of Rheumatology, Professor

    Autoimmune Disease, Rheumatology

  • ChangMin Kim, MD/PhD

    김창민2.png

    Korean Association for the Study of the Liver, Past President

    NASH/HCC

  • Heounjeong Go, MD/PhD

    go1.png

    Professor, University of Ulsan College of Medicine, Asan Medical Center, Department of Pathology

    Clinical Pathology

Preclinical Studies

  • Ho Lee, PhD

    이호.png

    National Cancer Center, Graduate School of Cancer Science and Policy, Professor

    Preclinical Animal Models

  • Ji-Woo Lee, DVM

    이지우.png

    Director of Pohang Animal Hospital

    Preclinical Animal Models

Scientific Studies

  • Hyung-Ho Ha, PhD

    하형호.png

    Sunchon National University, College of Pharmacy, Professor

    Medicinal Chemistry


  • Hyun-Soo Cho, PhD

    조현수.png

    Yonsei University, Department of Systems Biology, Professor

    Therapeutic Proteins

  • Myung-Hee Kwon, PhD

    kwon.png

    Ajou University School of Medicine, Department of Microbiology, Professor

    Antibody Drugs